October 22, 2020

The Niche

Knoepfler lab stem cell blog

Search Results for: mscs

6 min read

Graft-versus-host disease (GVHD) is counterintuitive In the weeks and months following a transplant, a major concern is the recipient’s immune system rejecting the “foreign” biological material. But in GVHD, the opposite happens: transplanted tissue unleashes a horde of T cells that spark a cascade of inflammation, within 100 days. Typically, GVHD follows a bone marrow transplant (BMT). Eighty Percent Mortality BMT has been used for more than half a century to treat and possibly cure certain cancers and single-gene conditions like sickle cell disease, …Read More

5 min read

Ready for the latest recommended weekly reads in the world of stem cells and the regenerative medicine space including a bunch of important new FDA posts & changes? This post has quite a lot on the FDA since it had a very big week with several new items of major importance to the cellular and regenerative medicine arena. I’ve linked to each announcement below with the agency’s title of the announcements. Underneath I provide some analysis and ask questions. I’ve also included some other stem …Read More

4 min read

Why is former Texas Governor/Trump Energy Secretary Rick Perry plugging unproven stem cells from a clinic firm called Celltex for COVID-19 prevention on Fox News? Perry follows in Giuliani’s footsteps? And more generally, what is it with conservative politicians promoting unproven therapies for COVID-19 and in particular stem cells for the novel coronavirus disease? First, we had Rudy Giuliani plugging what he called “stem cells” for COVID-19 on his webcast. This actually turned out to be natural killer (NK) cells, which are not stem …Read More

3 min read

Stem cells are always in the news so what’s up in the last week or two? CIRM News The dialogue over CIRM’s future is picking up a bit of steam. The San Francisco Chronicle did an in-depth piece on CIRM some weeks back and then opined that they didn’t feel supportive of another round of funding. I disagree. I think CIRM is a good future investment for California, but as a past CIRM grantee and stem cell advocate my opinion is probably not a …Read More